Novel potent and selective Ca2+ release-activated Ca2+ (CRAC) channel inhibitors. Part 3: synthesis and CRAC channel inhibitory activity of 4'-[(trifluoromethyl)pyrazol-1-yl]carboxanilides

Bioorg Med Chem. 2008 Nov 1;16(21):9457-66. doi: 10.1016/j.bmc.2008.09.047. Epub 2008 Sep 20.

Abstract

From a series of 4'-[(trifluoromethyl)pyrazol-1-yl]carboxanilides derived from 4-methyl-4'-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-1,2,3-thiadiazole-5-carboxanilide, one inhibited thapsigargin-induced Ca2+ influx in Jurkat T cells (IC(50)=77 nM) and exhibited high selectivity for the CRAC channel over the VOC channel (index: >130). Another acted as an inhibitor for both T lymphocyte activation-induced diseases and ovalbumin-induced airway eosinophilia in rats (ED(50)=1.3 mg/kg) p.o.

MeSH terms

  • Anilides / chemical synthesis
  • Anilides / chemistry
  • Anilides / pharmacology*
  • Animals
  • Calcium / metabolism*
  • Calcium Channel Blockers / chemical synthesis
  • Calcium Channel Blockers / chemistry
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / drug effects*
  • Calcium Signaling / drug effects
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Hypersensitivity / drug therapy
  • Interleukin-2 / metabolism
  • Jurkat Cells
  • Lymphocyte Activation / drug effects
  • Male
  • Mice
  • Pulmonary Eosinophilia / chemically induced
  • Pulmonary Eosinophilia / drug therapy
  • Pyrazoles / chemical synthesis
  • Pyrazoles / chemistry
  • Pyrazoles / pharmacology*
  • Rats
  • Rats, Inbred BN
  • Structure-Activity Relationship
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / metabolism
  • Thapsigargin / pharmacology

Substances

  • Anilides
  • Calcium Channel Blockers
  • Calcium Channels
  • Enzyme Inhibitors
  • Interleukin-2
  • Pyrazoles
  • Thapsigargin
  • Calcium